학술논문
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
Document Type
Article
Author
Source
In: Breast Cancer Research and Treatment . (Breast Cancer Research and Treatment, May 2023, 199(1):35-46)
Subject
Language
English
ISSN
15737217
01676806
01676806